Annual CFO
$8.42 B
-$745.81 M-8.14%
31 December 2023
Summary:
GSK annual cash flow from operations is currently $8.42 billion, with the most recent change of -$745.81 million (-8.14%) on 31 December 2023. During the last 3 years, it has fallen by -$2.41 billion (-22.26%). GSK annual CFO is now -36.80% below its all-time high of $13.32 billion, reached on 31 December 2008.GSK Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$2.88 B
+$1.49 B+106.37%
30 September 2024
Summary:
GSK quarterly cash flow from operations is currently $2.88 billion, with the most recent change of +$1.49 billion (+106.37%) on 30 September 2024. Over the past year, it has increased by +$63.91 million (+2.27%). GSK quarterly CFO is now -48.78% below its all-time high of $5.63 billion, reached on 31 December 2018.GSK Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$9.40 B
+$63.91 M+0.68%
30 September 2024
Summary:
GSK TTM cash flow from operations is currently $9.40 billion, with the most recent change of +$63.91 million (+0.68%) on 30 September 2024. Over the past year, it has increased by +$2.18 billion (+30.15%). GSK TTM CFO is now -32.51% below its all-time high of $13.92 billion, reached on 30 June 2022.GSK TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.1% | +2.3% | +30.1% |
| 3 y3 years | -22.3% | -17.6% | -12.0% |
| 5 y5 years | -25.1% | -3.5% | -16.6% |
GSK Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -23.0% | at low | -44.2% | +4377.9% | -32.5% | +67.2% |
| 5 y | 5 years | -25.1% | at low | -44.2% | +4377.9% | -32.5% | +67.2% |
| alltime | all time | -36.8% | +1139.3% | -48.8% | +168.3% | -32.5% | +390.6% |
GSK Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.88 B(+106.4%) | $9.40 B(+0.7%) |
| June 2024 | - | $1.40 B(+15.0%) | $9.33 B(-2.5%) |
| Mar 2024 | - | $1.22 B(-68.8%) | $9.57 B(+13.7%) |
| Dec 2023 | $8.42 B(-8.1%) | $3.90 B(+38.2%) | $8.42 B(+16.6%) |
| Sept 2023 | - | $2.82 B(+72.2%) | $7.22 B(+28.5%) |
| June 2023 | - | $1.64 B(+2442.4%) | $5.62 B(-3.5%) |
| Mar 2023 | - | $64.42 M(-97.6%) | $5.82 B(-36.5%) |
| Dec 2022 | $9.17 B(-16.2%) | $2.70 B(+121.1%) | $9.17 B(-21.2%) |
| Sept 2022 | - | $1.22 B(-33.7%) | $11.64 B(-16.4%) |
| June 2022 | - | $1.84 B(-46.0%) | $13.92 B(+0.2%) |
| Mar 2022 | - | $3.41 B(-34.0%) | $13.89 B(+27.0%) |
| Dec 2021 | $10.94 B(+1.0%) | $5.17 B(+47.6%) | $10.94 B(+2.5%) |
| Sept 2021 | - | $3.50 B(+93.2%) | $10.68 B(+25.9%) |
| June 2021 | - | $1.81 B(+297.2%) | $8.48 B(-15.6%) |
| Mar 2021 | - | $456.28 M(-90.7%) | $10.05 B(-7.2%) |
| Dec 2020 | $10.83 B(+5.8%) | $4.91 B(+275.5%) | $10.83 B(+2.8%) |
| Sept 2020 | - | $1.31 B(-61.4%) | $10.54 B(-13.8%) |
| June 2020 | - | $3.38 B(+173.5%) | $12.22 B(+15.2%) |
| Mar 2020 | - | $1.24 B(-73.2%) | $10.61 B(+3.6%) |
| Dec 2019 | $10.24 B(-8.9%) | $4.61 B(+54.3%) | $10.24 B(-9.0%) |
| Sept 2019 | - | $2.99 B(+68.6%) | $11.26 B(+3.9%) |
| June 2019 | - | $1.77 B(+105.3%) | $10.84 B(-0.5%) |
| Mar 2019 | - | $863.72 M(-84.7%) | $10.90 B(-3.0%) |
| Dec 2018 | $11.24 B(+25.8%) | $5.63 B(+119.0%) | $11.24 B(+21.7%) |
| Sept 2018 | - | $2.57 B(+40.4%) | $9.24 B(+0.2%) |
| June 2018 | - | $1.83 B(+52.7%) | $9.21 B(+5.7%) |
| Mar 2018 | - | $1.20 B(-67.0%) | $8.72 B(-2.4%) |
| Dec 2017 | $8.93 B(+1.5%) | $3.63 B(+42.5%) | $8.93 B(-6.0%) |
| Sept 2017 | - | $2.55 B(+91.1%) | $9.50 B(+4.9%) |
| June 2017 | - | $1.33 B(-5.8%) | $9.06 B(-4.7%) |
| Mar 2017 | - | $1.42 B(-66.2%) | $9.50 B(+7.9%) |
| Dec 2016 | $8.80 B(+124.2%) | $4.20 B(+99.2%) | $8.80 B(+28.0%) |
| Sept 2016 | - | $2.11 B(+18.5%) | $6.88 B(+24.5%) |
| June 2016 | - | $1.78 B(+146.9%) | $5.52 B(+35.2%) |
| Mar 2016 | - | $720.05 M(-68.3%) | $4.09 B(+4.1%) |
| Dec 2015 | $3.93 B(-54.0%) | $2.27 B(+200.5%) | $3.93 B(-25.0%) |
| Sept 2015 | - | $755.80 M(+123.4%) | $5.24 B(-20.5%) |
| June 2015 | - | $338.30 M(-39.7%) | $6.58 B(-12.9%) |
| Mar 2015 | - | $560.83 M(-84.3%) | $7.56 B(-11.4%) |
| Dec 2014 | $8.53 B(-24.5%) | $3.58 B(+70.3%) | $8.53 B(+1.0%) |
| Sept 2014 | - | $2.10 B(+59.9%) | $8.44 B(-12.1%) |
| June 2014 | - | $1.32 B(-14.2%) | $9.60 B(-11.8%) |
| Mar 2014 | - | $1.53 B(-56.1%) | $10.90 B(-3.6%) |
| Dec 2013 | $11.30 B(+63.0%) | $3.49 B(+7.0%) | $11.30 B(+4.1%) |
| Sept 2013 | - | $3.26 B(+25.2%) | $10.85 B(+52.4%) |
| June 2013 | - | $2.61 B(+34.6%) | $7.12 B(-2.1%) |
| Mar 2013 | - | $1.94 B(-36.4%) | $7.28 B(+5.0%) |
| Dec 2012 | $6.93 B(-30.8%) | $3.05 B(-754.1%) | $6.93 B(-5.0%) |
| Sept 2012 | - | -$465.79 M(-116.9%) | $7.30 B(-31.5%) |
| June 2012 | - | $2.76 B(+73.8%) | $10.66 B(+6.3%) |
| Mar 2012 | - | $1.59 B(-53.4%) | $10.03 B(+0.1%) |
| Dec 2011 | $10.02 B | $3.41 B(+17.9%) | $10.02 B(+13.5%) |
| Sept 2011 | - | $2.90 B(+35.8%) | $8.83 B(+12.1%) |
| June 2011 | - | $2.13 B(+34.8%) | $7.87 B(-10.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | $1.58 B(-28.7%) | $8.75 B(-16.5%) |
| Dec 2010 | $10.48 B(-14.7%) | $2.22 B(+14.2%) | $10.48 B(-8.0%) |
| Sept 2010 | - | $1.94 B(-35.4%) | $11.39 B(-13.5%) |
| June 2010 | - | $3.01 B(-9.1%) | $13.16 B(+0.5%) |
| Mar 2010 | - | $3.31 B(+5.7%) | $13.10 B(+6.6%) |
| Dec 2009 | $12.28 B(-7.8%) | $3.13 B(-15.8%) | $12.28 B(-4.8%) |
| Sept 2009 | - | $3.72 B(+26.4%) | $12.90 B(+3.2%) |
| June 2009 | - | $2.94 B(+17.9%) | $12.50 B(+2.0%) |
| Mar 2009 | - | $2.49 B(-33.4%) | $12.26 B(-8.0%) |
| Dec 2008 | $13.32 B(+8.0%) | $3.75 B(+12.8%) | $13.32 B(+8.6%) |
| Sept 2008 | - | $3.32 B(+23.1%) | $12.27 B(-6.4%) |
| June 2008 | - | $2.70 B(-24.3%) | $13.11 B(+1.5%) |
| Mar 2008 | - | $3.56 B(+32.6%) | $12.91 B(+4.6%) |
| Dec 2007 | $12.34 B(+53.7%) | $2.69 B(-35.4%) | $12.34 B(-3.4%) |
| Sept 2007 | - | $4.16 B(+66.2%) | $12.78 B(+55.6%) |
| June 2007 | - | $2.50 B(-16.3%) | $8.21 B(+3.9%) |
| Mar 2007 | - | $2.99 B(-4.2%) | $7.90 B(-1.6%) |
| Dec 2006 | $8.03 B(-25.9%) | $3.12 B(-873.8%) | $8.03 B(+0.2%) |
| Sept 2006 | - | -$403.30 M(-118.4%) | $8.01 B(-26.7%) |
| June 2006 | - | $2.19 B(-29.7%) | $10.93 B(-6.6%) |
| Mar 2006 | - | $3.12 B(+0.6%) | $11.70 B(+8.0%) |
| Dec 2005 | $10.84 B(+19.7%) | $3.10 B(+23.2%) | $10.84 B(+14.0%) |
| Sept 2005 | - | $2.52 B(-15.1%) | $9.50 B(+9.9%) |
| June 2005 | - | $2.97 B(+31.6%) | $8.65 B(-2.4%) |
| Mar 2005 | - | $2.25 B(+27.5%) | $8.86 B(-2.1%) |
| Dec 2004 | $9.06 B(+14.2%) | $1.77 B(+6.4%) | $9.06 B(+49.7%) |
| Sept 2004 | - | $1.66 B(-47.8%) | $6.05 B(-25.5%) |
| June 2004 | - | $3.18 B(+30.0%) | $8.12 B(-6.2%) |
| Mar 2004 | - | $2.45 B(-297.5%) | $8.66 B(+9.2%) |
| Dec 2003 | $7.93 B(+72.5%) | -$1.24 B(-133.2%) | $7.93 B(+60.2%) |
| Sept 2003 | - | $3.74 B(+0.4%) | $4.95 B(+2.2%) |
| June 2003 | - | $3.72 B(+116.5%) | $4.85 B(+14.0%) |
| Mar 2003 | - | $1.72 B(-140.7%) | $4.25 B(-7.6%) |
| Dec 2002 | $4.60 B(-30.7%) | -$4.22 B(-216.3%) | $4.60 B(-47.4%) |
| Sept 2002 | - | $3.63 B(+16.1%) | $8.74 B(+14.9%) |
| June 2002 | - | $3.12 B(+51.2%) | $7.61 B(+6.0%) |
| Mar 2002 | - | $2.07 B(-2731.1%) | $7.18 B(+8.1%) |
| Dec 2001 | $6.64 B(+136.5%) | -$78.55 M(-103.2%) | $6.64 B(+66.5%) |
| Sept 2001 | - | $2.49 B(-7.6%) | $3.99 B(-18.9%) |
| June 2001 | - | $2.70 B(+76.6%) | $4.92 B(+103.2%) |
| Mar 2001 | - | $1.53 B(-156.0%) | $2.42 B(-13.8%) |
| Dec 2000 | $2.81 B(+240.2%) | -$2.73 B(-179.8%) | $2.81 B(-49.3%) |
| Sept 2000 | - | $3.42 B(+1599.9%) | $5.54 B(+161.6%) |
| June 2000 | - | $201.19 M(-89.5%) | $2.12 B(+10.5%) |
| Mar 2000 | - | $1.92 B | $1.92 B |
| Dec 1999 | $825.24 M(+21.4%) | - | - |
| Dec 1998 | $679.54 M(-32.6%) | - | - |
| Dec 1997 | $1.01 B(-24.0%) | - | - |
| Dec 1996 | $1.33 B(-32.9%) | - | - |
| Dec 1995 | $1.98 B(-48.9%) | - | - |
| June 1995 | $3.87 B(+145.2%) | - | - |
| June 1994 | $1.58 B(+4.6%) | - | - |
| June 1993 | $1.51 B(+30.4%) | - | - |
| June 1992 | $1.16 B(+1.3%) | - | - |
| June 1991 | $1.14 B | - | - |
FAQ
- What is GSK annual cash flow from operations?
- What is the all time high annual CFO for GSK?
- What is GSK annual CFO year-on-year change?
- What is GSK quarterly cash flow from operations?
- What is the all time high quarterly CFO for GSK?
- What is GSK quarterly CFO year-on-year change?
- What is GSK TTM cash flow from operations?
- What is the all time high TTM CFO for GSK?
- What is GSK TTM CFO year-on-year change?
What is GSK annual cash flow from operations?
The current annual CFO of GSK is $8.42 B
What is the all time high annual CFO for GSK?
GSK all-time high annual cash flow from operations is $13.32 B
What is GSK annual CFO year-on-year change?
Over the past year, GSK annual cash flow from operations has changed by -$745.81 M (-8.14%)
What is GSK quarterly cash flow from operations?
The current quarterly CFO of GSK is $2.88 B
What is the all time high quarterly CFO for GSK?
GSK all-time high quarterly cash flow from operations is $5.63 B
What is GSK quarterly CFO year-on-year change?
Over the past year, GSK quarterly cash flow from operations has changed by +$63.91 M (+2.27%)
What is GSK TTM cash flow from operations?
The current TTM CFO of GSK is $9.40 B
What is the all time high TTM CFO for GSK?
GSK all-time high TTM cash flow from operations is $13.92 B
What is GSK TTM CFO year-on-year change?
Over the past year, GSK TTM cash flow from operations has changed by +$2.18 B (+30.15%)